[웨비나] Fragment-Based Drug Discovery of Cofactor-Specific Inhibitors for p97 [한국시간 5월 20일 (목) 12 AM]
기간 : 2021-05-20 ~ 2021-05-20
시간 : 00:00:00 ~ 18:00
[ Webinar ]
Fragment-Based Drug Discovery of Cofactor-Specific Inhibitors for p97
[ Time ]
한국시간 5월 20일 (목) 12 AM
[ Presenter ] Sebastian Bothe PostDoc, Department of Biochemistry University of Wuerzburg, Germany
Dr Helge Schnerr Global Campaign Manager Sartorius
[ Overview ] The AAA-ATPase p97 is an essential protein involved in numerous cellular processes and plays a key role in multiple aspects of protein homeostasis. Its functional diversity is mediated through the interaction with many distinct cofactors. Due to its significant role in regulating a variety of physiological responses, p97 has emerged as a potential therapeutic target. In this webinar, Sebastian Bothe from the University of Würzburg will present a combined approach that exploits computer-based methods, including virtual screening of molecular databases and biochemical/biophysical techniques. Accelerate your research with a field-upgradeable, label-free biomolecule analysis platform. Octet® systems have become indispensable analytical instruments enabling a broad range of application and workflow requirements. In his presentation, Dr Helge Schnerr, Global Campaign Manager at Sartorius will provide an overview of label-free biolayer interferometry (BLI) and its benefits. Attend this webinar to learn more about: - How to select potential candidates - The use of biolayer interferometry (BLI) for fragment screenings - Developing label-free assays for small molecule characterization - Optimizing the measurement of small molecule inhibitors
싸토리우스코리아 웹사이트는 귀하의 사용자 경험을 개선하고 귀하의 관심사에 맞는 콘텐츠를 제공하기 위해 쿠키를 사용합니다.
본인은 Sartorius가 사용자 프로필을 생성하고 관심있는 관련 있는 광고를 제공하기 위해 본인과 관련된 데이터를 처리하는 데 동의합니다.
이 동의는 자발적이며 이 웹사이트를 사용하는데 필요하지 않으며 향후 언제든지 철회할 수 있습니다.